Cardiovascular Focus Aviir's core emphasis on cardiovascular risk assessment and metabolic disorders creates opportunities to upsell expanded panels, bundle standard care tests with novel diagnostics, and partner with clinics or payers to implement risk-stratified testing programs.

Lab Services Platform Leverage the CLIA-certified Irvine laboratory to offer contract testing, white-label diagnostic services, and co-development of new assays, enabling collaboration with CROs, biotech firms, or healthcare providers seeking compliant lab capacity.

Data and Interoperability The technology stack suggests readiness for cloud-based data management and analytics; develop selling points around secure data exchange, EHR integration, and AI-driven risk modeling to enhance test adoption and outcomes.

Strategic Partnerships Position Aviir for alliances with larger diagnostics players for distribution, licensing, or joint development to scale reach beyond mid-market channels while leveraging existing tests and capabilities.

Market Expansion Target national expansion into clinics, health systems, and payer networks with clear reimbursement strategies and direct-to-clinic sales to accelerate revenue growth and broaden market presence.